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Background
The major problem faced in current tuberculosis (TB)
therapy is intrinsic drug resistance of mycobacterium.
Hence, there is a need to develop ways to overcome
these resistance mechanisms. In the current work, we
have investigated the effect of citric acid coated magne-
tite nanoparticles in combination with rifampicin against
a wild type strain of Mycobacterium smegmatis.
Methods
We have studied the effect of rifampicin on growth of
cells, with and without the nanoparticles. Further, cellu-
lar uptake of nanoparticles was studied by transmission
electron microscopy. Since, permeability barrier and
drug efflux are responsible for intrinsic drug resistance,
we have performed accumulation and efflux studies on
common efflux pump substrate ethidium bromide (EtBr)
by semi automated fluorometric method in the presence
and absence of nanoparticles.
Results
Citric acid coated magnetite nanoparticles exhibited a
significant growth inhibition when used in combination
with rifampicin. However, nanoparticles alone did not
have any effect on mycobacterial growth. Enhanced
growth inhibition was seen in the presence of a combina-
tion of rifampicin and nanoparticles, which was even
more than rifampicin alone at the same concentration.
Uptake studies revealed that nanoparticles were interna-
lized by M. smegmatis. Transport studies on EtBr demon-
strate that, in presence of nanoparticles, the net EtBr
accumulation inside the cells was increased.
Conclusion
Citric acid coated magnetite nanoparticles enhanced the
antibacterial effect of rifampicin when used in combina-
tion with the drug. Increased accumulation of EtBr in
presence of nanoparticles indicates that, one of the pos-
sible reasons for this enhanced effect is enhanced intra-
cellular drug accumulation.
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